Scarletred

Anrufen Wegbeschreibung Website Service kontaktieren

SCARLETRED is the global leader in AI assisted objective skin imaging and disease analysis Dr. Harald Schnidar MBA.

SCARLETRED Holding GmbH develops innovative products for augmented digital skin analysis, personalised medicine and therapy. The company is headquartered in Vienna and was founded in 2012 by the Molecular Biologist Mag.

08/10/2026

If we were asked to summarize the AI in Dermatology Summit 2026 in one sentence:

The perfect mix of technical AI-development and high-end scientific research 🚀

Three summit-takeaways that made us reflect:

1️⃣ AI is everywhere, and the focus is on skin cancer.
Melanoma and skin cancer detection dominated many discussions. AI in inflammatory skin diseases still holds a lot of untapped potential.

2️⃣ Sensitivity and specificity remain the key balancing act.
Detecting as many melanomas as possible while reducing false positives, so that fewer lesions are biopsied or removed unnecessarily, was a recurring topic. Validated AI tools are what make that balance trustworthy.

3️⃣ Dermatology is one of the most versatile fields for digital transformation.
AI-driven skin clinimetry means faster data, faster results and faster drug development - requiring higher standards in data protection. This is what Scarletred®Vision is built for.

A big thank you to the Department of Dermatology of Medizinische Universität Wien for hosting!

Interested in our posters and latest research on AI-driven Injection Site Reaction Monitoring, Objective Psoriasis Lesion Scoring and AI in Wound Healing? 🔎

Reach out to us at [email protected] 📩

07/10/2026

Four days with a spotlight on the clinical perspective 🔎

Thank you, EADV - European Academy of Dermatology and Venereology, for a great congress in our home city! 🎡

Our team presented three posters on our latest research in skin clinimetry, powered by our AI agent ARORA®:

🔎 AI Precision Imaging for Epidermolysis Bullosa
🔎 Chronic Wound Assessment
🔎 Injection Site Reaction Monitoring

Our takeaway: the clinical perspective was front and centre. Several sessions focused on how dermatologists can capture high-quality clinical images.

The message was consistent: reliable image acquisition is the foundation for digital monitoring.

It's also the principle Scarletred®Vision is built on: standardized, quantifiable skin imaging data, safely collected and intuitively presented.

You missed talking to us in Vienna? Let's connect 📩 [email protected]

06/10/2026

What does it take to bring medical AI from EU to US markets?

SCARLETRED is proud to announce that Aravinda Kumaran, Quality Assurance and Regulatory Affairs Manager at SCARLETRED, will be speaking at the LISAvienna Regulatory Affairs Conference 2026. 🎤

Now in its tenth year, the conference brings together regulatory affairs professionals from medical device and IVD sectors to discuss market authorization under MDR, FDA, and related developments.

On stage, Aravinda Kumaran will present SCARLETRED’s experience navigating regulatory approval for AI-powered medical devices in Europe and the US, titled:

“Bringing AI-Powered Medical Devices to Market: Lessons from EU Technical Documentation and the Road to FDA Submission”.

Join us at the LISAvienna Regulatory Affairs Conference 2026 for practical insights into what it really takes to medical AI to international markets. 🌎

Save the date 🗓️
October 15th, 2026 | 13:20-14:35
LISAvienna Regulatory Affairs Conference ( )
Apothekertrakt, Schloss Schönbrunn, Vienna, Austria

🔗 Registration open until October 8, 2026: www.b2match.com/e/lisavienna-reg26

29/09/2026

1 in 50 people will experience alopecia areata in their lifetime.

Alopecia areata is an autoimmune disease that attacks hair follicles, causing sudden, often unpredictable patches of hair loss.

Alopecia can affect anyone, at any age. And its effects on mental health must not be overlooked.

There is no cure yet, but there is hope: Hair follicles stay alive, so regrowth is biologically possible.

Scarletred®Vision, powered by ARORA®AI, changes the way we monitor and analyse alopecia:

Our clinically validated Skin Intelligence Platform is quantifying active follicles, hair density, length, and thickness straight from a smartphone image.

No hardware, no guesswork. Just objective data.

September is Alopecia Awareness Month, but research is a year-round dedication. 💙

👉 Swipe through our slides to find out how SCARLETRED transforms the way we monitor Alopecia.

17/09/2026

🔬 SCARLETRED is heading to EADV Congress 2026!

We are proud to be part of Europe's leading congress on skin health. 🚀 Save the date!

️🗓 September 30th to October 3rd, 2026
📍Austria Center Vienna (ACV), Bruno-Kreisky-Platz 1, 1220 Vienna
🌟 Hosted by the European Academy of Dermatology and Venereology

Our team will be presenting three posters on AI-driven imaging and disease severity scoring, covering:

🔎 AI Precision Imaging and Analysis for Epidermolysis Bullosa
🔎 Three Dimensions of Wound Healing
🔎 Injection Site Reaction Monitoring Reimagined

All built on and powered by our CE-certified Skin Intelligence Platform Scarletred®Vision and our ARORA®AI agent.

"Vienna hosting the EADV Congress 2026 is a meaningful moment for us," says Dr. Harald Schnidar, CEO & Founder of SCARLETRED. "The team is looking forward to presenting the latest findings in AI-driven skin monitoring and disease severity scoring."

We are happy to meet you at EADV 2026 in our home city, Vienna! 🇦🇹

16/09/2026

🔬 SCARLETRED is proud to announce its presence at the AI in Dermatology Summit 2026!

🗓️ September 29, 2026
📍House of Engineers (Haus der Ingenieure) | Eschenbachgasse 9, 1010 Vienna, Austria
🌟 Hosted by the Department of Dermatology of the Medical University of Vienna (Medizinische Universität Wien)

From clinical integration to monitoring, detection and treatment of skin conditions: The summit gathers international experts to discuss the future of trustworthy AI for skin health.

SCARLETRED will present three posters:
📌 Three Dimensions of Wound Healing
📌 Injection Site Reaction Monitoring Reimagined
📌 Smart Imaging and Deep Learning for Objective Psoriasis Lesion Scoring

All powered by our CE-certified Skin Intelligence Platform Scarletred®Vision and our ARORA®AI agent.

We are looking forward to inspiring discussions! Feel free to reach out if you would like to connect with us at the summit. 📩

15/09/2026

ESDR, thank you for two eventful days! 🌟

Last week, Monika Molnarova, Senior Data Scientist, and Alessio Lampis, Data Scientist, represented SCARLETRED at the 55th European Society for Dermatological Research (ESDR) Annual Meeting in Heidelberg, Germany.

It was a pleasure to present our latest research on Objective Skin Typing and AI-Driven Fitzpatrick Classification from Facial Imagery as well as on AI Precision Imaging and Analysis for Epidermolysis Bullosa.

The annual meeting made us realize once again how Scarletred®Vision, our ARORA®AI-powered Skin Intelligence Platform, is transforming standardized, reproducible skin imaging in research and clinical settings.

It was inspiring to be surrounded by people pushing dermatological research forward! 🚀

10/09/2026

Our CEO & President of SCARLETRED, Dr. Harald Schnidar, will speak at the World Medical Innovation Forum 2026 as a panellist 🎤

Save the date!
🗓️ September 22-23, 2026
📍Westin Boston Seaport District | Boston, MA
🔗 worldmedicalinnovation.org

The World Medical Innovation Forum brings together global leaders to assess the latest opportunities and challenges in healthcare - a premier stage for healthcare innovation and investment.

Dr. Schnidar will represent SCARLETRED’s Austrian roots and its US headquarters of SCARLETRED Inc. in Cambridge, Massachusetts – with a clear vision:

“Combining standardized imaging with AI-driven analysis is what makes it possible to set a new standard in dermatology. A standard that clinicians, researcher and patients can trust.”

The World Medical Innovation Forum is presented by Mass General Brigham and the Bank of America.

28/08/2026

🔬 SCARLETRED research to be presented at ESDR 2026!

We are proud that our latest research will be featured at the 55th Annual ESDR Meeting, Europe's leading conference for skin research and dermatological science, taking place from September 9-12 in Heidelberg, Germany.

Two posters will showcase AI-driven imaging, analysis and disease severity scoring capabilities - covering objective skin typing and Epidermolysis Bullosa. All built on our CE-certified SaMD Scarletred®Vision, powered by ARORA®AI.

📅 Save the date:
📌 55th Annual ESDR Meeting
📌 September 9-12, 2026
📌 Heidelberg, Germany

27/08/2026

12 years, one core mission, making skin measurable. 🚀

Today, SCARLETRED celebrates its 12th anniversary.

What started in 2014 as a clinical imaging platform has evolved into Digital Skin Intelligence - combining standardized smartphone imaging, quantitative skin biomarkers, and medical AI to turn skin data into meaningful clinical insights.

12 years of science, clinical evidence, technology, and collaboration across 30+ countries.

From clinical research to routine care and the patient’s home, remote skin assessment is the future of digital dermatology - making objective skin data more accessible, scalable, and actionable.

Thanks to our partners, clinicians, researchers, patients, and everyone who has been part of the journey 🌟

Going beyond imaging - turning skin data into intelligence for better clinical decisions🌍

Adresse

MQM3. 4, Maria Jacobi Gasse 1, 8th Floor
Wien
1030

Telefon

+436644669807

Website

https://scarletred.com/

Benachrichtigungen

Erfahren Sie als Erste/r von Neuigkeiten und Aktionen: Wir schicken Ihnen eine E-Mail, wenn Scarletred etwas veröffentlicht. Ihre E-Mail-Adresse wird für keinen anderen Zweck verwendet, und Sie können sich jederzeit abmelden.